Press release
Segmentation, Major Trends, and Competitive Overview of the Organoids Market
Organoids Market
Projected Expansion of the Organoids Market Size Through 2030
The organoids market is anticipated to witness remarkable growth over the coming years, reaching a valuation of $13.13 billion by 2030. This expansion is expected to occur at a robust compound annual growth rate (CAGR) of 22.2%. Several factors contribute to this surge, including the broadening scope of personalized medicine, enhanced collaborations between pharmaceutical companies and organoid research firms, and a rise in regenerative medicine projects. Additionally, increased funding from both governmental and private sources for organoid-focused studies, along with the creation of organoid biobanks aimed at disease modeling, play critical roles. Key trends driving this growth include the growing implementation of organoids in drug discovery and personalized treatments, their expanding use in regenerative and tissue engineering fields, applications in studying infectious disease mechanisms, the development of disease-specific organoids for targeted therapy, and deeper integration of organoid models in preclinical drug testing for efficacy and toxicity.
Download a free report of the organoids market report:
https://www.thebusinessresearchcompany.com/report/organoids-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Top Companies Steering the Organoids Market Forward
The organoids market features several influential companies making significant contributions, such as Cellesce Ltd., STEMCELL Technologies, HUB Organoids, DefiniGEN, OcellO B.V., Organoid Therapeutics, InSphero AG, Axol Bioscience Ltd., TissUse GmbH, Epithelix Sàrl, SUN Bioscience, Prellis Biologics, Epistem, MIMETAS BV, Organoidsciences Ltd., Zenit Science, Biomorgan, TheWell Bioscience Inc., CN Bio Innovations Ltd., TARA Biosystems, Nortis Inc., Newcells Biotech, Known Medicine, Dynomics Inc., CHA Biotech Co Ltd, and Tempus AI Inc. A notable development occurred in December 2024 when Merck KGaA, a leading life sciences company based in Germany, acquired HUB Organoids Holding B.V. Although the financial terms were not disclosed, this acquisition aims to broaden Merck's next-generation biology portfolio by incorporating HUB Organoids' proprietary technologies, including model creation, assay development, and high-throughput screening. HUB Organoids, located in the Netherlands, is recognized for its foundational patents in organoid biology and its provision of advanced organoid technology services.
Factors Encouraging Growth in the Organoids Market
One significant factor propelling the organoids market is the rising adoption of organoid models in personalized medicine and drug discovery. These models offer enhanced precision in understanding patient-specific disease mechanisms and drug responses, which accelerates the development of tailored treatments.
Another driving force is the growing investment in regenerative medicine and tissue engineering applications. Organoids provide a platform to replicate human tissue structures, facilitating advances in repairing or replacing damaged organs, which is attracting considerable funding and research focus globally.
View the full organoids market report:
https://www.thebusinessresearchcompany.com/report/organoids-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Innovative Trends Enhancing Organoids Market Expansion
Research and industry leaders are increasingly focusing on disease-specific organoids, which enable targeted therapeutic development. These specialized organoids aid in modeling complex diseases more effectively, opening avenues for novel treatment options.
Further, the market is witnessing greater integration of organoid models in preclinical drug testing to evaluate drug efficacy and toxicity. This not only shortens the drug development timeline but also improves the accuracy of predictions related to human responses, thereby reducing clinical trial failures.
How the Organoids Market Is Categorized
The organoids market is divided into several segments for a detailed understanding:
1) By Product: Hepatic Organoid, Colorectal Organoid, Intestinal Organoid, and Other Products
2) By Application: Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, and Other Applications
3) By End-User: Hospitals and Diagnostic Centers, Biotechnology and Pharmaceutical Companies, and Other End-Users
Further Breakdown of Product Subcategories
For hepatic organoids, the subsegments include hepatic stem cell-derived organoids, primary liver cell-derived organoids, and liver tumor organoids.
Colorectal organoids are further classified into colonic organoids, rectal organoids, and colorectal cancer organoids.
Intestinal organoids consist of small intestinal organoids, enteroid organoids, and intestinal stem cell-derived organoids.
The "Other Products" category encompasses pancreatic organoids, brain organoids, kidney organoids, and lung organoids.
These detailed classifications provide a comprehensive view of the organoids market, highlighting its diverse applications and broadening scope as it moves toward a highly innovative future.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Segmentation, Major Trends, and Competitive Overview of the Organoids Market here
News-ID: 4495556 • Views: …
More Releases from The Business Research Company
Market Driver Insights: The Impact of Recent Advancements on the Periodontal Dis …
The periodontal disease treatment market is on track for significant expansion in the coming years. With innovations in treatment methods and growing awareness among patients, this sector is preparing to meet increasing demand and evolving healare needs. Let's explore the market's current size, key drivers, prominent players, future trends, and segmentation details to understand the trajectory of this important healare field.
Projected Growth and Market Size of the Periodontal Disease Treatment…
Peptic Ulcer Market Overview: Major Segments, Strategic Developments, and Leadin …
The peptic ulcer market is positioned for consistent advancement as healare innovations and treatment accessibility continue to improve. With ongoing developments in diagnostic tools and therapeutic options, this sector is expected to witness steady expansion over the coming years. Here is a detailed overview of the market's valuation, key players, driving trends, and segment insights shaping its future.
Projected Market Valuation and Growth Trajectory of the Peptic Ulcer Market
The peptic…
Segmentation, Major Trends, and Competitive Overview of the Pelvic Inflammatory …
The pelvic inflammatory disease (PID) treatment market is gearing up for notable expansion in the coming years. With advancements in medical therapies and growing awareness around early diagnosis, this market is set to experience steady growth and evolving treatment strategies. Let's explore the forecasted market size, key players, influential trends, and market segmentation to better understand what lies ahead.
Projected Expansion and Market Size of the Pelvic Inflammatory Disease Treatment Industry…
Leading Companies Fueling Growth and Innovation in the Pediatric Neuroblastoma T …
The pediatric neuroblastoma treatment market is poised for significant expansion as advancements in medical research and technology continue to accelerate. With a focus on innovative therapies and improved patient care, this sector is expected to experience robust growth in the coming years. Below is a detailed overview of the market's size, key players, driving factors, and emerging trends shaping its future.
Pediatric Neuroblastoma Treatment Market Size and Growth Outlook
The market…
More Releases for Organoid
Advancing Human Hair Research with Skin Organoid Models
Hair research plays a critical role in addressing common conditions such as androgenetic alopecia, hair thinning, and hair graying. Yet, despite decades of study, the development of effective therapies has been slow. One major reason is the limited ability of conventional research models to accurately reflect the complexity of human hair follicle biology.
Recent advances in human skin organoid technology are reshaping this landscape. Skin organoids provide a three-dimensional, human-relevant platform…
4Dcell Achieves 95% Organoid Reproducibility Breakthrough With Patented Anchorin …
4Dcell announced that its SmartSphero plates have achieved over 95% reproducibility in organoid size and shape, while reducing organoid loss during medium exchanges to below 12%, a significant improvement over the 86% loss seen in traditional unanchored systems. This breakthrough addresses a persistent challenge in pharmaceutical drug screening and safety testing, where inconsistent organoid cultures have often hindered data reliability.
The company's patented Anchoring Point Technology (APT®) allows researchers to culture…
Organoid Culture Medium Research:the global Organoid Culture Medium market size …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Organoid Culture Medium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
…
Organoid Technology Market Size, Growth, In-depth Analysis, Research Report Fore …
The organoid technology market is estimated to grow at a CAGR of 27.12% during the forecast period.
The prime factors propelling the growth of the organoid technology market are increasing demand for personalized medicine, drug discovery and development, and regenerative medicine.
As per the report, the organoid technology market is expected to grow rapidly during the forecast period.
Organoids are three-dimensional cell cultures that mimic the structure and function of human organs, making…
Organoid Technology Market Trends, Future Demands, Growth Factors, Emerging Tech …
The global Organoids and Spheroids Market size was valued at $516.6 million in 2021 and is projected to reach $1.2 billion by 2031, growing at a CAGR of 8.5% from 2022 to 2031.
Organoid technology bridges the gap between conventional two-dimensional cell line culture and in vivo models. The near-physiological technology can virtually recapitulates organ development and human diseases, such as infectious diseases, genetic abnormality and even cancers.
Between traditional two-dimensional cell…
Organoids Market Driven By Definigen, Organoid Therapeutics, Hubrecht Organoid T …
The scope of the organoids market includes type, application, source, and region. The organoids market is analyzed based on regions, such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the organoids market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.…
